Navigation Links
Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
Date:3/31/2008

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic Initiatives (PSI), a provider of marketing consultation and content development services to the pharmaceutical industry, has added Anne L. Sexton MD, MS to its management team as Vice President of Medical Activities.

Dr. Sexton brings 15 years of clinical and pharmaceutical experience to PSI. Dr. Sexton's broad experience includes medical affairs and medical monitoring, drug development strategy, regulatory affairs activities including FDA submissions, drug safety/pharmacovigilance and medical writing.

According to PSI President Charles Carter, PhD, "Anne brings the clinical and industry experience our customers need to develop and implement their integrated medical affairs strategies and support regulatory initiatives."

Prior to joining PSI, Dr. Sexton headed an independent consulting company serving the pharmaceutical and biotech industries.

About Pharmaceutical Strategic Initiatives

PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of Interactive Holdings. PSI provides strategic marketing consultation and content development services to the pharmaceutical industry. For more information about PSI, contact Mary Messina at 919.314.1380 or visit http://www.psillc.com.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
4. Barr Pharmaceuticals, Inc. Executive Bios
5. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
6. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
7. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
8. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
11. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... Freed-Hardeman University President Joe A. Wiley ... joint enrollment and degree completion agreement. The agreement, which begins with the ... FHU|Dickson. , The agreement allows students to be jointly admitted to both ...
(Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... IL (PRWEB) , ... February 05, 2016 , ... In ... disguised form as a dream. A hallmark feature of patients with eating disorders is ... needs. The eating disorder behaviors and obsessions are regarded as maladaptive means for coping ...
(Date:2/5/2016)... ... February 05, 2016 , ... KICVentures ( http://www.kicventures.com ... Development event in New York City on Thursday, January 21, 2016. Kingsley ... Mediacom, (both alumnus of the varsity Columbia soccer program) spoke at the event, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Obstetrics ... company profile to their offering. ... addition of the "Global Obstetrics Partnering ... company profile to their offering. --> ...
(Date:2/4/2016)... Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... structural heart disease and critical care monitoring, announced today ... (ASR) agreement with Morgan Stanley & Co. LLC to ... is part of the Company,s previously authorized program to ... stock.  --> --> ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
Breaking Medicine Technology: